Pathways linking depression, adiposity, and inflammatory markers in healthy young adults

Brain, Behavior, and Immunity

Volumn 17, Issue 4, 2003, Pages 276-285

  Miller, Gregory E ^a   Freedland, Kenneth E ^b   Carney, Robert M ^b   Stetler, Cinnamon A ^a   Banks, William A ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary disease; Cytokines; Depression; Inflammation; Leptin; Obesity; Psychoneuroimmunology; Sickness behavior

Indexed keywords

INTERLEUKIN 6; LEPTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH STATUS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE; MALE; NORMAL HUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; WEIGHT GAIN;

EID: 0038047054     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00057-6     Document Type: Article

References (55)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. American Psychiatric Association: Washington DC.
2. Anda R.F., Williamson D., Jones D. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 4:1993;285-294.
3. Appels A., Bar F.W., Bar J., Bruggeman C., de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom. Med. 62:2000;601-605.
4. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
5. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiat. 5:1961;462-467.
6. Bentler P.M. Comparitive fit indices in structural equation models. Psychol. Bull. 107:1990;238-246.
7. Bentler P.M. EQS: Structural equations program manual. 1995;BMDP Statistical Software, Los Angeles, CA.
8. Bentler P.M., Bonett D.G. Significance tests and goodness of fit in the analysis of covariance structure. Psychol. Bull. 88:1980;588-606.
9. Bower J.E., Ganz P.A., Aziz N., Fahey J.L. Fatigue and pro-inflammatory cytokine activity in breast cancer survivors. Psychosom. Med. 64:2002;604-611.
10. Capuron L., Ravaud A., Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J. Clin. Oncol. 18:2000;2143-2151.
11. Capuron L., Ravaud A., Gualde N., Bosmans E., Dantzer R., Maes M., Neveu J. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2 based therapy. Psychoneuroendocrinology. 26:2001;797-808.
12. Carney R.M., Freedland K.E., Miller G.E., Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J. Psychosom. Res. 53:2002;897-902.
13. Danesh J., Collins R., Appleby P., Peto R. Fibrinogen, C-reactive protein, albumin, and white cell count: Meta-analyses of prospective studies of coronary heart disease. J. Am. Med. Assoc. 279:2000;1477-1482.
14. Dantzer R. Cytokine-induced sickness behavior: Where do we stand? Brain. Behav. Immun. 15:2001;7-24.
15. Das U.N. Is obesity an inflammatory condition? Nutrition. 17:2001;953-966.
16. Dentino A.N., Pieper C.F., Rao K.M.K., Currie M.S., Harris T., Blazer D.G., Cohen H.J. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J. Am. Geriatric. Soc. 47:1999;6-11.
17. Everson S.A., Goldberg D.E., Kaplan G.A., Cohen R.D., Pukkala E., Tuomilehto J., Salonen J.T. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom. Med. 58:1996;113-121.
18. Fantuzzi G., Faggioni R. Leptin the regulation of immunity, inflammation, and hemotapoesis. J. Leukoc. Biol. 68:2000;437-446.
19. Ford D.E., Mead L.A., Chang P.P., Cooper-Patrick L., Wang N.Y., Klag M.J. Depression is a risk factor for coronary artery disease in men: The precursors study. Arch. Intern. Med. 158:1998;1422-1426.
20. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. J. Am. Med. Assoc. 270:1993;1819-1825.
21. Frasure-Smith N., Lesperance F., Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 91:1995;999-1005.
22. Freedland K.E., Skala J.A., Carney R.M., Raczynski J.M., Taylor C.B.et al. The depression interview and structured Hamilton (DISH): Rationale, development, characteristics, and clinical validity. Psychosom. Med. 64:2002;897-905.
23. Gabay C., Kushner I. Acute phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:1999;448-454.
24. Glassman A.H., Shapiro P.A. Depression and the course of coronary artery disease. Am. J. Psychiat. 155:1998;4-11.
25. Jequier E. Leptin signaling, adiposity, and energy balance. Ann. N. Y. Acad. Sci. 967:2002;379-388.
26. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. 280:2001;E745-E751.
27. Kop W.J., Cohen N. Psychological risk factors and immune system involvement in cardiovascular disease. Ader R., Felten D., Cohen N. Psychoneuroimmunology. 2001;525-544 Academic Press, New York.
28. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., Newman A.B., Hirsch C., Tracy R.P. Inflammatory and coagulation factors in persons. > 65 years of age with symptoms of depression but without evidence of myocardial ischemia Am. J. Cardiol. 89:2002;419-424.
29. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 104:2001;365-372.
30. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., Klein A.S., Bulkley G.B., Bao C., Noble P.W., Lane M.D., Diehl A.M. Leptin regulates proinflammatory immune responses. FASEB J. 12:1998;57-65.
31. Lutgendorf S.K., Garand L., Buckwalter K.C., Reimer T.T., Hong S.Y., Lubaroff D.M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J. Gerontol. Biol. Sci. Med. Sci. 54:1999;M434-M439.
32. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 9:1997;853-858.
33. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disorders. 34:1995;301-309.
34. Maier S.F., Watkins L.R. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105:1998;83-107.
35. McDonald R.P., Ho M.H.R. Principles and practice in reporting structural equation analyses. Psychol. Meth. 7:2002;64-82.
36. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 90:2002;1279-1283.
37. Mohamed-Ali V., Goodrick S., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α in vivo. J. Clin. Endocrinol. Metab. 82:1997;4196-4200.
38. Mohr D., Goodkin D., Islar J., Hauser S., Genain C.P. Treatment of depression is associated with suppression of nonspecific and antigen-specific Th1 responses in multiple sclerosis. Arch. Neurol. 58:2001;1081-1086.
39. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. Arch. Gen. Psychiat. 55:1998;580-592.
40. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., Greiner K., Nemeroff C.B., Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344:2001;961-966.
41. Pratt L.A., Ford D.E., Crum R.M., Armenian H.K., Gallo J.J., Eaton W.W. Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up. Circulation. 94:1996;3123-3129.
42. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiat. 58:2001;445-452.
43. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979.
44. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843.
45. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101:2000;1767-1772.
46. Robins L.N., Helzer J.E., Croughan J., Ratcliff K. The NIMH diagnostic interview schedule: Its history, characteristics, and validity. Arch. Gen. Psychiat. 38:1981;381-389.
47. Ross R. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
48. Santos-Alvarez J., Goberna R., Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 194:1999;6-11.
49. Spitzer R.L., Williams J.B.W., Kroenke K., Linzer M., deGruy F.V., Hahn S.R., Brody D., Johnson J.G. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. J. Am. Med. Assoc. 272:1994;1749-1756.
50. Suarez, E.C., Krishnan, K.R., Lewis, J.G., in press. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med.
51. Thakore J.H., Richards P.J., Reznek R.H., Martin A., Dinan T.G. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol. Psychiat. 41:1997;1140-1142.
52. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol. Today. 16:1995;27-33.
53. Williams J.B.W. A structured interview guide for the Hamilton depression rating scale. Arch. Gen. Psychiat. 45:1988;742-747.
54. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 711:1996;163-174.
55. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease: Is interleukin-6 the link? Atherosclerosis. 148:2001;209-214.